UBS Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $99.8M | Sell |
408,100
-185,996
| -31% | -$43.3M | 0.02% | 1050 |
|
|
2025
Q4 | $123M | Sell |
594,096
-26,099
| -4% | -$5.16M | 0.02% | 871 |
|
|
2025
Q3 | $115M | Buy |
620,195
+92,463
| +18% | +$15.8M | 0.02% | 928 |
|
|
2025
Q2 | $80.6M | Sell |
527,732
-180,963
| -26% | -$27.8M | 0.01% | 1125 |
|
|
2025
Q1 | $118M | Sell |
708,695
-424,800
| -37% | -$66.5M | 0.02% | 824 |
|
|
2024
Q4 | $164M | Buy |
1,133,495
+224,000
| +25% | +$34.7M | 0.03% | 614 |
|
|
2024
Q3 | $147M | Buy |
909,495
+306,000
| +51% | +$48.8M | 0.03% | 536 |
|
|
2024
Q2 | $88.2M | Buy |
603,495
+98,100
| +19% | +$14.6M | 0.02% | 709 |
|
|
2024
Q1 | $79.9M | Sell |
505,395
-191,942
| -28% | -$30.6M | 0.02% | 760 |
|
|
2023
Q4 | $109M | Buy |
697,337
+397,537
| +133% | +$61M | 0.03% | 534 |
|
|
2023
Q3 | $46.7M | Buy |
299,800
+45,870
| +18% | +$7.57M | 0.02% | 902 |
|
|
2023
Q2 | $42M | Buy |
253,930
+106,600
| +72% | +$17.2M | 0.01% | 928 |
|
|
2023
Q1 | $22.8M | Sell |
147,330
-84,070
| -36% | -$13.6M | 0.01% | 1299 |
|
|
2022
Q4 | $40.9M | Buy |
231,400
+70,570
| +44% | +$12.2M | 0.02% | 922 |
|
|
2022
Q3 | $26.3M | Buy |
160,830
+69,630
| +76% | +$11.8M | 0.01% | 1091 |
|
|
2022
Q2 | $16.2M | Sell |
91,200
-44,500
| -33% | -$7.93M | 0.01% | 1462 |
|
|
2022
Q1 | $24.1M | Sell |
135,700
-116,500
| -46% | -$19.8M | 0.01% | 1292 |
|
|
2021
Q4 | $43.1M | Buy |
252,200
+135,979
| +117% | +$22.3M | 0.01% | 1053 |
|
|
2021
Q3 | $18.8M | Sell |
116,221
-50,200
| -30% | -$8.56M | 0.01% | 1547 |
|
|
2021
Q2 | $27.4M | Sell |
166,421
-385,200
| -70% | -$63.8M | 0.01% | 1246 |
|
|
2021
Q1 | $90.7M | Buy |
551,621
+457,721
| +487% | +$74.1M | 0.03% | 556 |
|
|
2020
Q4 | $14.8M | Buy |
93,900
+1,700
| +2% | +$251K | 0.01% | 1555 |
|
|
2020
Q3 | $13.7M | Buy |
92,200
+77,200
| +515% | +$11.4M | 0.01% | 1429 |
|
|
2020
Q2 | $2.11M | Sell |
15,000
-527,200
| -97% | -$76.8M | ﹤0.01% | 2822 |
|
|
2020
Q1 | $71.1M | Buy |
542,200
+477,000
| +732% | +$67.7M | 0.03% | 438 |
|
|
2019
Q4 | $9.51M | Buy |
65,200
+54,300
| +498% | +$7.37M | ﹤0.01% | 2002 |
|
|
2019
Q3 | $1.41M | Sell |
10,900
-300
| -3% | -$39.5K | ﹤0.01% | 3652 |
|
|
2019
Q2 | $1.56M | Sell |
11,200
-101,600
| -90% | -$14.1M | ﹤0.01% | 3374 |
|
|
2019
Q1 | $15.8M | Buy |
112,800
+100,370
| +807% | +$13.4M | 0.01% | 1318 |
|
|
2018
Q4 | $1.6M | Buy |
12,430
+8,800
| +242% | +$1.23M | ﹤0.01% | 3252 |
|
|
2018
Q3 | $502K | Sell |
3,630
-319,386
| -99% | -$42.4M | ﹤0.01% | 4399 |
|
|
2018
Q2 | $39.2M | Sell |
323,016
-77,184
| -19% | -$9.63M | 0.02% | 780 |
|
|
2018
Q1 | $51.3M | Buy |
400,200
+316,400
| +378% | +$42.8M | 0.02% | 628 |
|
|
2017
Q4 | $11.7M | Buy |
83,800
+34,750
| +71% | +$4.84M | ﹤0.01% | 1594 |
|
|
2017
Q3 | $6.38M | Sell |
49,050
-260,950
| -84% | -$34.6M | ﹤0.01% | 1990 |
|
|
2017
Q2 | $41M | Buy |
310,000
+400
| +0.1% | +$51K | 0.02% | 658 |
|
|
2017
Q1 | $38.6M | Buy |
309,600
+77,300
| +33% | +$9.23M | 0.02% | 661 |
|
|
2016
Q4 | $26.8M | Buy |
232,300
+65,800
| +40% | +$7.6M | 0.01% | 851 |
|
|
2016
Q3 | $19.7M | Buy |
166,500
+90,685
| +120% | +$11M | 0.01% | 993 |
|
|
2016
Q2 | $9.2M | Sell |
75,815
-51,985
| -41% | -$5.91M | 0.01% | 1444 |
|
|
2016
Q1 | $13.8M | Sell |
127,800
-115,900
| -48% | -$12M | 0.01% | 1112 |
|
|
2015
Q4 | $25M | Buy |
243,700
+127,300
| +109% | +$12.8M | 0.02% | 834 |
|
|
2015
Q3 | $10.9M | Sell |
116,400
-128,954
| -53% | -$12.5M | 0.01% | 1309 |
|
|
2015
Q2 | $23.9M | Buy |
245,354
+149,654
| +156% | +$15M | 0.02% | 864 |
|
|
2015
Q1 | $9.63M | Buy |
95,700
+55,600
| +139% | +$5.65M | 0.01% | 1512 |
|
|
2014
Q4 | $4.19M | Buy |
+40,100
| New | +$4.23M | ﹤0.01% | 2246 |
|
Other funds holding JNJ
VCM
VPM
UBS Group's JNJ Position: Q1 2026 in Review
UBS Group increased its Johnson & Johnson (JNJ) stake by 2.3% in Q1 2026, buying an estimated $52.4M and bringing the position to 10,209,327 shares worth $2.5B. The position accounts for 0.37% of the portfolio, ranked #33.
UBS Group first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- UBS Group held 10,209,327 shares of Johnson & Johnson worth $2.5B as of Q1 2026.
- UBS Group bought 225,036 Johnson & Johnson shares in Q1 2026, an estimated $52.4M.
- Johnson & Johnson made up 0.37% of UBS Group's portfolio in Q1 2026, its #33 holding.
- UBS Group first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.